BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 67 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $33,000 | -23.3% | 14,472 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $43,000 | 0.0% | 14,472 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $43,000 | +19.4% | 14,472 | +12.5% | 0.00% | +33.3% |
| Q2 2017 | $36,000 | 0.0% | 12,859 | -32.2% | 0.00% | 0.0% |
| Q1 2017 | $36,000 | +2.9% | 18,959 | -6.4% | 0.00% | -25.0% |
| Q4 2016 | $35,000 | -57.3% | 20,259 | -33.3% | 0.00% | -60.0% |
| Q3 2016 | $82,000 | +12.3% | 30,359 | -2.5% | 0.01% | 0.0% |
| Q2 2016 | $73,000 | -20.7% | 31,137 | +9.3% | 0.01% | -23.1% |
| Q1 2016 | $92,000 | -31.9% | 28,484 | +0.9% | 0.01% | -31.6% |
| Q4 2015 | $135,000 | -82.3% | 28,233 | -79.4% | 0.02% | -84.3% |
| Q3 2015 | $762,000 | -0.3% | 136,963 | +42.8% | 0.12% | +15.2% |
| Q2 2015 | $764,000 | -17.8% | 95,926 | +8.3% | 0.10% | -14.6% |
| Q1 2015 | $930,000 | -16.8% | 88,560 | -4.8% | 0.12% | -16.9% |
| Q4 2014 | $1,118,000 | – | 92,982 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 2,000,000 | $7,820,000 | 6.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $37,262,000 | 0.78% |
| EMC Capital Management | 193,906 | $758,000 | 0.54% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,486,454 | $13,632,000 | 0.50% |
| ALGERT GLOBAL LLC | 344,210 | $1,346,000 | 0.43% |
| Hillsdale Investment Management Inc. | 877,000 | $3,430,000 | 0.29% |
| Stanley-Laman Group, Ltd. | 349,465 | $1,366,000 | 0.22% |
| SHEPHERD KAPLAN KROCHUK, LLC | 94,000 | $368,000 | 0.14% |
| GLOBEFLEX CAPITAL L P | 178,474 | $698,000 | 0.13% |
| Zebra Capital Management LLC | 23,622 | $92,000 | 0.10% |